{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:39:36Z","timestamp":1789666776456,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bbamem.2021.183629","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T23:42:46Z","timestamp":1619739766000},"page":"183629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Peptide-mediated leishmaniasis management strategy: Tachyplesin emerges as an effective anti-leishmanial peptide against Leishmania donovani"],"prefix":"10.1016","volume":"1863","author":[{"given":"Vivek","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Chugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamem.2021.183629_bb0005","first-page":"1","article-title":"What constitutes a neglected tropical disease?","volume":"14","author":"Hotez","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbamem.2021.183629_bb0010","author":"Accelerated plan for kala-azar elimination"},{"key":"10.1016\/j.bbamem.2021.183629_bb0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1099\/jmm.0.076695-0","article-title":"Cutaneous leishmaniasis caused by Leishmania donovani in the tribal population of the Agasthyamala Biosphere Reserve forest, Western Ghats, Kerala, India clinical manifestations","volume":"64","author":"Kumar","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.bbamem.2021.183629_bb0020","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/ijd.12748","article-title":"Mucocutaneous leishmaniasis caused by Leishmania donovani infection in an Indian man","volume":"54","author":"Daulatabad","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.bbamem.2021.183629_bb0025","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4103\/ijmr.IJMR_335_16","article-title":"Is elimination of kala-azar feasible by 2017?","volume":"144","author":"Thakur","year":"2018","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.bbamem.2021.183629_bb0035","author":"WHO"},{"key":"10.1016\/j.bbamem.2021.183629_bb0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12879-019-4719-3","article-title":"Intensely clustered outbreak of visceral leishmaniasis (kala-azar) in a setting of seasonal migration in a village of Bihar, India","volume":"20","author":"Kumar","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bbamem.2021.183629_bb0045","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1016\/S1473-3099(16)30140-2","article-title":"Elimination of visceral leishmaniasis on the Indian subcontinent","volume":"16","author":"Singh","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbamem.2021.183629_bb0050","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.bbamem.2021.183629_bb0055","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12879-019-4083-3","article-title":"Molecular evidence supports the expansion of visceral leishmaniasis towards non- program districts of Nepal","volume":"19","author":"Shrestha","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bbamem.2021.183629_bb0060","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.pt.2019.06.007","article-title":"Post kala-azar dermal leishmaniasis as a reservoir for visceral leishmaniasis transmission trends in parasitology","volume":"35","author":"Le Rutte","year":"2019","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bbamem.2021.183629_bb0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/cid\/ciy891","article-title":"Quantifying the infectiousness of post-kala-azar dermal leishmaniasis toward sand flies","volume":"69","author":"Mondal","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbamem.2021.183629_bb0070","series-title":"Vaccines for Visceral Leishmaniasis: Hopes and Hurdles","author":"Khalil","year":"2018"},{"key":"10.1016\/j.bbamem.2021.183629_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbamem.2021.183629_bb0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","article-title":"Amphotericin B: side effects and toxicity","volume":"26","author":"Noem\u0131","year":"2009","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.bbamem.2021.183629_bb0085","doi-asserted-by":"crossref","unstructured":"Sunter J, Gull K. Shape, form, function and Leishmania pathogenicity: from textbook descriptions to biological understanding. Open Biol. 2017;7.","DOI":"10.1098\/rsob.170165"},{"key":"10.1016\/j.bbamem.2021.183629_bb0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbamem.2016.11.002","article-title":"CyLoP-1: membrane-active peptide with cell-penetrating and anti-microbial properties","volume":"1859","author":"Ponnappan","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bbamem.2021.183629_bb0095","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/febs.13178","article-title":"Marine anti-microbial peptide tachyplesin as an efficient nanocarrier for macromolecule delivery in plant and mammalian cells","volume":"282","author":"Jain","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.bbamem.2021.183629_bb0100","doi-asserted-by":"crossref","first-page":"119286","DOI":"10.1016\/j.biomaterials.2019.119286","article-title":"Targeted delivery of anti-microbial peptide by Cry protein crystal to treat intramacrophage infection","volume":"217","author":"Yang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbamem.2021.183629_bb0105","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jconrel.2012.05.023","article-title":"Defeating Leishmania resistance to Miltefosine (hexadecylphosphocholine) by peptide-mediated drug smuggling: a proof of mechanism for trypanosomatid chemotherapy","volume":"161","author":"Luque-ortega","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbamem.2021.183629_bb0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jcb.24654","article-title":"Transduction of proteins into Leishmania tarentolae by formation of non-covalent complexes with cell-penetrating peptides","volume":"252","author":"Keller","year":"2014","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbamem.2021.183629_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.exppara.2007.07.011","article-title":"Trypanocidal and leishmanicidal activities of different anti-microbial peptides (AMPs) isolated from aquatic animals","volume":"118","author":"Miletti","year":"2008","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bbamem.2021.183629_bb0120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.addr.2007.09.005","article-title":"Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy","volume":"60","author":"Deshayes","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbamem.2021.183629_bb0125","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.bbamem.2010.06.005","article-title":"Structural polymorphism of non-covalent peptide-based delivery systems: highway to cellular uptake","volume":"1798","author":"Deshayes","year":"2010","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bbamem.2021.183629_bb0130","first-page":"1245","article-title":"Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic \u03b1-helical anti-microbial peptides","volume":"2006","author":"Sato","year":"1758","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bbamem.2021.183629_bb0135","doi-asserted-by":"crossref","first-page":"17070","DOI":"10.1038\/cddiscovery.2017.70","article-title":"Cell death and cell lysis are separable events during pyroptosis","volume":"3","author":"DiPeso","year":"2017","journal-title":"Cell Death Discov."},{"issue":"e1141","key":"10.1016\/j.bbamem.2021.183629_bb0140","article-title":"Effect of BMAP-28 antimicrobial peptides on Leishmania major promastigote and amastigote growth: role of leishmanolysin in parasite survival","volume":"5","author":"Pante","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bbamem.2021.183629_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.exppara.2009.05.002","article-title":"Experimental parasitology. Antiplasmodial and antileishmanial activities of phylloseptin-1, an anti-microbial peptide from the skin secretion of Phyllomedusa azurea (Amphibia)","volume":"123","author":"K\u00fcckelhaus","year":"2009","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bbamem.2021.183629_bb0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.exppara.2009.03.019","article-title":"Leishmania donovani: thionins, plant antimicrobial peptides with leishmanicidal activity","volume":"122","author":"Berrocal-lobo","year":"2009","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bbamem.2021.183629_bb0155","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1074\/jbc.M410795200","article-title":"Temporins, small antimicrobial peptides with leishmanicidal activity","volume":"280","author":"Mangoni","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamem.2021.183629_bb0160","first-page":"1817","article-title":"Human anti-microbial peptide histatin 5 is a cell- penetrating peptide targeting mitochondrial ATP synthesis in Leishmania","volume":"22","author":"Roma","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamem.2021.183629_bb0165","first-page":"868","article-title":"Anti-microbial peptides for leishmaniasis","volume":"11","author":"Cobb","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.bbamem.2021.183629_bb0170","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/AAC.05349-11","article-title":"Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo","volume":"56","author":"Erfe","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbamem.2021.183629_bb0175","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/AAC.02328-15","article-title":"Identification of synthetic and natural host defense peptides with","volume":"60","author":"Marr","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbamem.2021.183629_bb0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.micres.2014.08.012","article-title":"Mechanism of tachyplesin I injury to bacterial membranes and intracellular enzymes, determined by laser confocal scanning microscopy and flow cytometry","volume":"170","author":"Hong","year":"2015","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.bbamem.2021.183629_bb0185","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1128\/AAC.02459-14","article-title":"Induction of mitochondrial dysfunction and oxidative stress in leishmania donovani by orally active clerodane diterpene","volume":"58","author":"Kathuria","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbamem.2021.183629_bb0190","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2217\/fmb.12.85","article-title":"Modes of action of Leishmanicidal anti-microbial peptides","volume":"7","author":"Marr","year":"2012","journal-title":"Future Microbiol."},{"key":"10.1016\/j.bbamem.2021.183629_bb0195","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1016\/j.bbagen.2017.08.003","article-title":"Membrane targeting peptides toward antileishmanial activity: design, structural determination and mechanism of interaction","volume":"1861","author":"Martins","year":"2017","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"10.1016\/j.bbamem.2021.183629_bb0200","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3389\/fmicb.2018.00825","article-title":"Tachyplesin causes membrane instability that kills multidrug-resistant bacteria by inhibiting the 3-ketoacyl carrier protein reductase FabG","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbamem.2021.183629_bb0205","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2174\/138945012802002393","article-title":"Antimicrobial peptide action on parasites","volume":"13","author":"Torrent","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbamem.2021.183629_bb0210","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11745-017-4233-6","article-title":"Changes in lipid and fatty acid composition during intramacrophagic transformation of Leishmania donovani complex promastigotes into amastigotes","volume":"52","author":"Bouazizi","year":"2017","journal-title":"Lipids"},{"key":"10.1016\/j.bbamem.2021.183629_bb0215","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s40475-019-00187-w","article-title":"Alterations in host lipid metabolism produced during visceral leishmaniasis infections","volume":"6","author":"Mart\u00ednez","year":"2019","journal-title":"Curr. Trop. Med. Rep."},{"key":"10.1016\/j.bbamem.2021.183629_bb0220","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1021\/bi970588v","article-title":"Membrane permeabilization mechanisms of a cyclic anti-microbial peptide, Tachyplesin I, and its linear analog","volume":"36","author":"Matsuzaki","year":"1997","journal-title":"Biochemistry."},{"key":"10.1016\/j.bbamem.2021.183629_bb0225","first-page":"1160","article-title":"Action mechanism of tachyplesin I and effects of PEGylation","volume":"2007","author":"Imura","year":"1768","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bbamem.2021.183629_bb0230","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.3390\/ijms20174184","article-title":"Characterization of tachyplesin peptides and their cyclized analogues to improve anti-microbial and anticancer properties","volume":"20","author":"Vernen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbamem.2021.183629_bb0235","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0014-4894(77)90107-2","article-title":"Leishmania donovani: surface membrane carbohydrates of promastigotes","volume":"41","author":"Dwyer","year":"1977","journal-title":"Exp. Parasitol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273621000808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273621000808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T08:57:57Z","timestamp":1757753877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0005273621000808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0005273621000808"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamem.2021.183629","relation":{},"ISSN":["0005-2736"],"issn-type":[{"value":"0005-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptide-mediated leishmaniasis management strategy: Tachyplesin emerges as an effective anti-leishmanial peptide against Leishmania donovani","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Biomembranes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamem.2021.183629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"183629"}}